Showing results (1-10 of 261) with videos related to
Sort By:
Pageof 27
Blood|January 11, 2003
Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcriptionSansana Sawasdikosol, Kristin M Russo, Steven J BurakoffNature Reviews. Immunology|May 11, 2002
Cytolytic pathways in haematopoietic stem-cell transplantationMarcel R M van den Brink, Steven J BurakoffClinical Prostate Cancer|March 30, 2004
The evolving role of estrogen therapy in prostate cancerWilliam K OhThe Journal of Urology|November 13, 2004
An overview of chemotherapy trials in localized and recurrent nonmetastatic prostate cancerWilliam K OhThe Oncologist|November 8, 2005
High-risk localized prostate cancer: integrating chemotherapyWilliam K OhUrologic Oncology|June 18, 2003
Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpointsWilliam K OhThe Journal of Urology|November 12, 2003
The evolving role of chemotherapy and other systemic therapies for managing localized prostate cancerWilliam K OhUrology|September 17, 2002
Secondary hormonal therapies in the treatment of prostate cancerWilliam K OHAIDS Research and Therapy|July 28, 2010
Alkylating HIV-1 Nef - a potential way of HIV interventionYong-Jiu Jin, Xiaoping Zhang, Catherine Yi Cai, et al.The Journal of Biological Chemistry|September 27, 2007
Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathwaySansana Sawasdikosol, Saiju Pyarajan, Saba Alzabin, et al.Pageof 27